For the Inventor, By the Inventor

Enter assignee name

Fremont, CA, United States of America

Abgenix, Inc.

USPTO Granted Patents = 32

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 6,750

Loading Chart...

Loading Chart...

52 inventors (with patents filed for the assignee):

Aya Jakobovits (14 out of 189 patents)

Raju S Kucherlapati (8 out of 18 patents)

Jose Corvalan (7 out of 34 patents)

4. Daniel J Capon (6 out of 29 patents)

5. Larry L Green (6 out of 71 patents)

6. Daniel G Brenner (6 out of 7 patents)

7. Sue Klapholz (5 out of 11 patents)

8. Xiao-Chi Jia (4 out of 57 patents)

9. Vahe Bedian (4 out of 29 patents)

10. Krisztina M Zsebo (4 out of 30 patents)

11. Ronald P Gladue (3 out of 15 patents)

12. Xiao Feng (3 out of 22 patents)

13. C Geoffrey Davis (3 out of 15 patents)

14. Menashe Bar-Eli (3 out of 4 patents)

15. Michael Gallo (2 out of 20 patents)

32 patents: Sort by Forward Citations

1. 8236530 - Method for preparing monoclonal antibody (2012-08-07),

2. 7563442 - Antibodies to CD40 and methods of treating cancer and enhancing immune responses (2009-07-21),

3. 7422742 - Methods for using human monoclonal antibodies to interleukin-5 (2008-09-09),

4. 7338660 - Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 (2008-03-04),

5. 7326414 - Antibodies to M-CSF (2008-02-05),

6. 7288251 - Antibodies to CD40 (2007-10-30),

7. 7202343 - Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof (2007-04-10),

8. 7145056 - Production of antibodies using cre-mediated site-specific recombination (2006-12-05),

9. 7141653 - Human monoclonal antibodies to interleukin-5 (2006-11-28),

10. 7109003 - Methods for expressing and recovering human monoclonal antibodies to CTLA-4 (2006-09-19),

11. 7090844 - Use of antibodies against the MUC18 antigen (2006-08-15),

12. 7078492 - Human antipneumococcal antibodies from non-human animals (2006-07-18),

13. 7067131 - Methods for using anti-MUC18 antibodies (2006-06-27),

14. 7064244 - [object Object] (2006-06-20),

15. 7049426 - Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions (2006-05-23),

Abgenix, Inc. is a biotechnology company specializing in the discovery and development of fully human monoclonal antibodies for the treatment of various diseases. With a focus on using XenoMouse technology, Abgenix aims to provide innovative therapeutic solutions that harness the power of the human immune system. Through strategic partnerships and cutting-edge research, the company strives to revolutionize the field of antibody-based therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

32 Patents

#60 in Fremont, CA

#2,459 in California

#10,247 in US

#20,095 in the World

Fremont, CA, United States of America

Abgenix, Inc.

Forward Citations = 6,750

52 inventors:

Aya Jakobovits (14 out of 189 patents)

Raju S Kucherlapati (8 out of 18 patents)

Jose Corvalan (7 out of 34 patents)

4. Daniel J Capon (6 out of 29 patents)

5. Larry L Green (6 out of 71 patents)

Please report any incorrect information to support@idiyas.com

Loading…